ISEF AlumniNewscovid-19 cure

EXOCD24, currently in phase I clinical trial at Tel Aviv’s Sourasky Medical Center, has enabled 100% (30 out of 30) moderately to severely ill COVID patients to recover in a matter of days. Initial results show that the treatment stops the lethal immune “overreaction” to the virus before it destroys healthy cells.

ISEF Alumnus Prof. Ronni Gamzu, CEO of Sourasky Medical Center, is now seeking approval from Israel’s Ministry of Health for further research. Prof Gamzu says the research “is advanced and sophisticated and may save coronavirus patients.” You can learn more about this exciting news here.